Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Biol Psychiatry. 2012 Apr 18;72(4):331–338. doi: 10.1016/j.biopsych.2012.03.004

Table 1.

Demographic and Treatment Characteristics of the Patient Sample

MDD (n = 45) BD (n = 22) χ2, p
n (%) n (%)
Gender (Male) 28 (62) 6 (27) 7.22, .007
Response Rate to Ketamine at 230 Minutes 17 (38) 15 (68) 5.48, .02
Mean (SD) Mean (SD) t, p
Age, Years 46.8 (12.9) 44.8 (11.7) .62, .54
Weight 93.3 (23.5) 91.5 (19.0) .33, .75
BMI 30.2 (6.6) 31.8 (5.9) −.96, .34
Clinical Scales
 MADRS 32.8 (4.7) 31.7 (3.8) .98, .33
 BPRS total 36.1 (5.9) 34.9 (4.6) .88, .38
 BPRS positive 9.7 (1.4) 9.9 (1.5) −.45, .65
 CADSS 4.3 (7.5) 2.1 (3.4) 1.36, .18
 Percent change in MADRSa −37.3 (32.1) −46.5 (33.6) 1.08, .28

BD, bipolar depression; BMI, body mass index; BPRS, Brief Psychiatric Rating Scale; CADSS, Clinician Administered Dissociative States Scale; MADRS, Montgomery–Åsberg Depression Rating Scale; MDD, major depressive disorder; SD, standard deviation.

a

From baseline to end point.